Transmembrane-Bound IL-15–Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Natural Science Foundation of China (81101563)
- National Natural Science Foundation of China (91129728)
- National Natural Science Foundation of China (91429308)
- National Natural Science Foundation of China (81422050)
This publication has 38 references indexed in Scilit:
- Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires β-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent PathwaysJournal of Biological Chemistry, 2012
- Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the γc Signaling PathwayPLOS ONE, 2012
- Differentiation Therapy: Targeting Human Renal Cancer Stem Cells with Interleukin 15JNCI: Journal of the National Cancer Institute, 2011
- Differences in integrin expression and signaling within human breast cancer cellsBMC Cancer, 2011
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transitionMolecular Biology of the Cell, 2011
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaquesBlood, 2011
- Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinomaBritish Journal of Cancer, 2009
- Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis†Hepatology, 2009
- Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15RαPLOS ONE, 2009
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006